Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9

Oncology Reports

Volumn 32, Issue 2, 2014, Pages 794-800

  Guo, Nan ^a   Liu, Fayu ^c   Yang, Liangliang ^c   Huang, Jinying ^b   Ding, Xue ^c   Sun, Changfu ^c  

^a Department of Head and Neck Surgery ^*  (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CCR7; Migration; MMP 9; SCCHN

Indexed keywords

2 [[(4 PHENOXYPHENYL)SULFONYL]METHYL]THIIRANE; CHEMOKINE RECEPTOR CCR7; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; CCR7 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ACTIN POLYMERIZATION ASSAY; ADULT; ARTICLE; BIOASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GELATIN ZYMOGRAPHY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA CELL LINE; UPREGULATION; WESTERN BLOTTING; AGED; CELL MOTION; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL19; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, CCR7;

EID: 84903146799     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3242     Document Type: Article

References (27)

1. Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG and Shim H: CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67: 7518-7524, 2007. (Pubitemid 47206582)
2. Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, El-Naggar AK, Mills GB and Myers JN: Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133: 15-23, 2007. (Pubitemid 46129500)
3. Yanagawa Y and Onoé K: CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100: 1948-1956, 2002. (Pubitemid 35001222)
4. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, Tabira Y, Akagi J, Nomiyama H and Yoshie O: A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol 28: 1516-1523, 1998. (Pubitemid 28221154)
5. Takanami I: Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105: 186-189, 2003.
6. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
7. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol 35: 19-24, 2009.
8. Günther K, Leier J, Henning G, Dimmler A, Weissbach R, Hohenberger W and Förster R: Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 116: 726-733, 2005.
9. Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and Sun CF: Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 48: 291-296, 2010.
10. Zhao ZJ, Liu FY and Sun CF: Effect of chemokine receptor 7 small interfering RNA on proliferation and invasion of squamous cell carcinoma of head and neck. Zhonghua Kou Qiang Yi Xue Za Zhi 44: 5-10, 2009 (In Chinese).
11. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
12. Corcoran ML, Hewitt RE, Kleiner DE Jr and Stetler-Stevenson WG: MMP-2: expression, activation and inhibition. Enzyme Protein 49: 7-19, 1996. (Pubitemid 26181734)
13. Hong SD, Hong SP, Lee JI and Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36: 207-216, 2000.
14. Du B, Wang P, Juo X and Du B: Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. Pathol Oncol Res 5: 214-219, 1999.
15. Flavell JR, Baumforth KR, Williams DM, et al: Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status. Mol Pathol 53: 145-149, 2000. (Pubitemid 30396455)
16. Maruyama S, Kawata R, Shimada T, et al: Study of matrix metalloproteinase-2 and -9 in thyroid papillary cancer. Nihon Jibiinkoka Gakkai Kaiho 103: 499-505, 2000 (In Japanese).
17. Jäälinojä J, Herva R, Korpela M, et al: Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 46: 81-90, 2000. (Pubitemid 30352615)
18. Li Y, Liu W, Fang L, Nan J, Zhang Z and Zhou Q: Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression. Zhongguo Fei Ai Za Zhi 13: 1016-1020, 2010 (In Chinese).
19. Sato H and Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993. (Pubitemid 23073756)
20. Strup-Perrot C, Vozenin-Brotons MC, Vandamme M, et al: Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol 41: 60-70, 2006. (Pubitemid 43030893)
21. Ogata Y, Matono K, Nakajima M, et al: Efficacy of the MMP inhibitor MMI270 against lung metastasis following removal of orthotopically transplanted human colon cancer in rat. Int J Cancer 118: 215-221, 2006. (Pubitemid 41681602)
22. Brand S, Dambacher J, Beigel F, et al: CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310: 117-130, 2005. (Pubitemid 41393693)
23. Sun RH, Wang GB, Li J and Cui J: Role of CCL21/CCR7 in invasion of colorectal carcinoma cell line SW480. Ai Zheng 28: 708-713, 2009 (In Chinese).
24. Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24: 5897-5904, 2005. (Pubitemid 43080081)
25. Zhou HY, Wan KF, Ip CK, Wong CK, Mak NK, Lo KW and Wong AS: Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. FEBS Lett 582: 3415-3422, 2008.
26. Kurahara S, Shinohara M, lkebe T, et al: Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627-638, 1999. (Pubitemid 29459868)
27. Li P, Zhao ZJ, Liu FY, Sun LY, Ding X, Zhang WZ, Shang DH and Sun CF: The chemokine receptor 7 regulates cell adhesion and migration via β1 integrin in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 24: 989-995, 2010.